Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3h4g | FID | Alcohol dehydrogenase [NADP(+)] | 1.1.1.2 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3h4g | FID | Alcohol dehydrogenase [NADP(+)] | 1.1.1.2 | 1.000 | |
| 3cv7 | C2U | Alcohol dehydrogenase [NADP(+)] | 1.1.1.2 | 0.547 | |
| 2pd9 | FID | Aldose reductase | 1.1.1.21 | 0.526 | |
| 4gab | FID | Aldo-keto reductase family 1 member B10 | 1.1.1 | 0.524 | |
| 2pdw | FID | Aldose reductase | 1.1.1.21 | 0.523 | |
| 1pwm | FID | Aldose reductase | 1.1.1.21 | 0.513 | |
| 2pdk | SBI | Aldose reductase | 1.1.1.21 | 0.511 | |
| 3u2c | SUZ | Aldose reductase | 1.1.1.21 | 0.510 | |
| 2f2k | TGG | Aldose reductase | 1.1.1.21 | 0.507 | |
| 3s3g | TLT | Aldose reductase | 1.1.1.21 | 0.501 | |
| 3fx4 | FX4 | Alcohol dehydrogenase [NADP(+)] | 1.1.1.2 | 0.497 | |
| 2is7 | 2CL | Aldose reductase | 1.1.1.21 | 0.496 | |
| 3p2v | DOY | Aldose reductase | 1.1.1.21 | 0.493 | |
| 3v35 | NTI | Aldose reductase | 1.1.1.21 | 0.485 | |
| 2iej | S48 | Protein farnesyltransferase subunit beta | 2.5.1.58 | 0.484 | |
| 1yw7 | A41 | Methionine aminopeptidase 2 | / | 0.482 | |
| 2pdj | 393 | Aldose reductase | 1.1.1.21 | 0.479 | |
| 2pdy | FID | Aldose reductase | 1.1.1.21 | 0.479 | |
| 1eko | I84 | Aldose reductase | 1.1.1.21 | 0.477 | |
| 5kf2 | ACO | Predicted acetyltransferase | / | 0.477 | |
| 1dlr | MXA | Dihydrofolate reductase | 1.5.1.3 | 0.473 | |
| 1ef3 | FID | Aldose reductase | 1.1.1.21 | 0.472 | |
| 2iqd | LPA | Aldose reductase | 1.1.1.21 | 0.472 | |
| 5liu | 388 | Aldo-keto reductase family 1 member B10 | 1.1.1 | 0.472 | |
| 2vi5 | Y19 | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.471 | |
| 2ea4 | F79 | Methionine aminopeptidase 2 | / | 0.466 | |
| 2fzb | TOL | Aldose reductase | 1.1.1.21 | 0.466 | |
| 1gt5 | BZQ | Odorant-binding protein | / | 0.465 | |
| 2agt | FID | Aldose reductase | 1.1.1.21 | 0.465 | |
| 2inz | OHP | Aldose reductase | 1.1.1.21 | 0.465 | |
| 2nvc | ITA | Aldose reductase | 1.1.1.21 | 0.465 | |
| 3f3y | 4OA | Bile salt sulfotransferase | 2.8.2.14 | 0.464 | |
| 1ah0 | SBI | Aldose reductase | 1.1.1.21 | 0.462 | |
| 3rsv | 3RS | Beta-secretase 1 | 3.4.23.46 | 0.462 | |
| 3szf | DCQ | Sulfide-quinone reductase | / | 0.462 | |
| 2pdl | TOL | Aldose reductase | 1.1.1.21 | 0.461 | |
| 2r6k | GTX | Glutathione S-transferase A1 | 2.5.1.18 | 0.461 | |
| 1yw9 | A84 | Methionine aminopeptidase 2 | / | 0.460 | |
| 5kgj | ACO | Predicted acetyltransferase | / | 0.460 | |
| 3v36 | NAP | Aldose reductase | 1.1.1.21 | 0.459 | |
| 2poq | ISD | Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase | 1.3.1.20 | 0.458 | |
| 4lsa | BLD | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.458 | |
| 3dop | NAP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.457 | |
| 1lnm | DTX | Bilin-binding protein | / | 0.456 | |
| 2ea2 | F77 | Methionine aminopeptidase 2 | / | 0.456 | |
| 2pdi | ZST | Aldose reductase | 1.1.1.21 | 0.456 | |
| 3uzz | TES | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.456 | |
| 3t0k | DCQ | Sulfide-quinone reductase | / | 0.455 | |
| 1pq9 | 44B | Oxysterols receptor LXR-beta | / | 0.454 | |
| 1pqc | 444 | Oxysterols receptor LXR-beta | / | 0.454 | |
| 2gms | P0P | Putative pyridoxamine 5-phosphate-dependent dehydrase | / | 0.452 | |
| 5std | UNN | Scytalone dehydratase | 4.2.1.94 | 0.452 | |
| 2ga2 | A19 | Methionine aminopeptidase 2 | / | 0.451 | |
| 2ikj | 393 | Aldose reductase | 1.1.1.21 | 0.451 | |
| 2ouu | 35G | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.451 | |
| 2o8h | 227 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.450 | |
| 2pdh | 47D | Aldose reductase | 1.1.1.21 | 0.450 | |
| 2r86 | ATP | 5-formaminoimidazole-4-carboxamide-1-(beta)-D-ribofuranosyl 5'-monophosphate synthetase | / | 0.450 | |
| 4ajd | F04 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.450 | |
| 4wev | SUZ | Aldo-keto reductase family 1 member B10 | 1.1.1 | 0.450 | |
| 4xzj | NAD | Putative NAD(+)--arginine ADP-ribosyltransferase Vis | 2.4.2.31 | 0.450 | |
| 1e6z | NGO | Chitinase | / | 0.449 | |
| 1yw8 | A75 | Methionine aminopeptidase 2 | / | 0.449 | |
| 2bjs | ACV | Isopenicillin N synthase | 1.21.3.1 | 0.449 | |
| 1zua | TOL | Aldo-keto reductase family 1 member B10 | 1.1.1 | 0.448 | |
| 2pdm | ZST | Aldose reductase | 1.1.1.21 | 0.448 | |
| 3gyu | DL7 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.448 | |
| 1el3 | I84 | Aldose reductase | 1.1.1.21 | 0.447 | |
| 1g63 | FMN | Epidermin decarboxylase | 4.1.1 | 0.447 | |
| 1ni4 | TPP | Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial | 1.2.4.1 | 0.447 | |
| 1ni4 | TPP | Pyruvate dehydrogenase E1 component subunit beta, mitochondrial | 1.2.4.1 | 0.447 | |
| 2pdf | ZST | Aldose reductase | 1.1.1.21 | 0.447 | |
| 3blo | QEI | Queuine tRNA-ribosyltransferase | 2.4.2.29 | 0.447 | |
| 3dva | TPW | Pyruvate dehydrogenase E1 component subunit alpha | 1.2.4.1 | 0.447 | |
| 3dva | TPW | Pyruvate dehydrogenase E1 component subunit beta | 1.2.4.1 | 0.447 | |
| 1zq5 | E04 | Aldo-keto reductase family 1 member C3 | / | 0.446 | |
| 2vrj | NCW | Beta-glucosidase A | 3.2.1.21 | 0.446 | |
| 3rvi | RVI | Beta-secretase 1 | 3.4.23.46 | 0.446 | |
| 3sn7 | 540 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.446 | |
| 4ddl | 0JQ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.446 | |
| 4jq2 | SUZ | Aldo-keto reductase family 1 member C2 | / | 0.446 | |
| 4jq4 | IMN | Aldo-keto reductase family 1 member C2 | / | 0.446 | |
| 1el4 | CTZ | Obelin | / | 0.445 | |
| 1p8d | CO1 | Oxysterols receptor LXR-beta | / | 0.445 | |
| 2ipw | 2CL | Aldose reductase | 1.1.1.21 | 0.445 | |
| 3sni | 546 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.445 | |
| 5kf9 | ACO | Predicted acetyltransferase | / | 0.445 | |
| 3ghs | LDT | Aldose reductase | 1.1.1.21 | 0.444 | |
| 4lm4 | JPZ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.444 | |
| 2qx7 | NAP | Eugenol synthase 1 | 1.1.1.318 | 0.443 | |
| 4g2y | NI5 | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.443 | |
| 1e2l | TMC | Thymidine kinase | / | 0.442 | |
| 2fm5 | M99 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.442 | |
| 2o6h | INI | 6,7-dimethyl-8-ribityllumazine synthase 1 | 2.5.1.78 | 0.442 | |
| 2ovv | PFH | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.442 | |
| 3uph | 0C1 | Genome polyprotein | 2.7.7.48 | 0.442 | |
| 4bfu | ZVU | Pantothenate kinase | 2.7.1.33 | 0.442 | |
| 4jtr | IBP | Aldo-keto reductase family 1 member C2 | / | 0.442 | |
| 1qv0 | CZH | Obelin | / | 0.441 | |
| 3zv7 | NHG | Acetylcholinesterase | 3.1.1.7 | 0.441 | |
| 4llk | MEW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 | |
| 1az1 | ALR | Aldose reductase | 1.1.1.21 | 0.440 | |
| 1az2 | NAP | Aldose reductase | 1.1.1.21 | 0.440 | |
| 1xor | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.440 | |
| 2acu | NAP | Aldose reductase | 1.1.1.21 | 0.440 | |
| 2ouy | CMP | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
| 3hmv | HBT | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 3.1.4.53 | 0.440 | |
| 4ajf | F03 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
| 4hf4 | 15H | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
| 4jtr | IZP | Aldo-keto reductase family 1 member C2 | / | 0.440 |